It can accurately block the interaction between PD-1 and programmed death ligand 1 (PD-L1), relieve immune suppression mediated by the PD-1 pathway, promote T-cell proliferation and cytokine generation, and exert anti-tumor effects. This evidence concerns the gene PDCD1 and neoplasm.